Jump to content

Butidrine

From Wikipedia, the free encyclopedia
Butidrine
Clinical data
Trade namesBetabloc, Butidrate, Recetan
Other namesButedrine; Butydrine; Hydrobutamine; Idrobutamine
Drug classBeta blocker
Identifiers
  • 2-(butan-2-ylamino)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethanol
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H25NO
Molar mass247.382 g·mol−1
3D model (JSmol)
  • CCC(C)NCC(C1=CC2=C(CCCC2)C=C1)O
  • InChI=1S/C16H25NO/c1-3-12(2)17-11-16(18)15-9-8-13-6-4-5-7-14(13)10-15/h8-10,12,16-18H,3-7,11H2,1-2H3
  • Key:GVNYSERWAKVROD-UHFFFAOYSA-N

Butidrine (INNTooltip International Nonproprietary Name), sold under the brand names Betabloc, Butidrate, and Recetan among others, is a beta blocker (or β-adrenergic receptor antagonist) related to pronethalol[1] and propranolol[2] that was developed in the 1960s.[3][4] It is not cardioselective (i.e., is not selective for the β1-adrenergic receptor over the β2-adrenergic receptor).[5] It has membrane stabilizing activity but no intrinsic sympathomimetic activity (i.e., partial agonist activity).[6] Similarly to certain other beta blockers, butidrine additionally possesses local anesthetic properties.[7]

References

[edit]
  1. ^ Bristol JA (1986). Cardiovascular drugs. John Wiley & Sons, Incorporated. p. 111. ISBN 978-0-471-09228-5.
  2. ^ Drug Metabolism Reviews. Marcel Dekker. 1972.
  3. ^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 58–. ISBN 978-94-011-4439-1.
  4. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 197–. ISBN 978-1-4757-2085-3.
  5. ^ Sokabe, Hirofumi (1985). "A new classification of β-adrenoceptor blocking drugs". Trends in Pharmacological Sciences. 6: 107–109. doi:10.1016/0165-6147(85)90051-3.
  6. ^ Fitzgerald JD (1969). "Perspectives in adrenergic beta-receptor blockade". Clin Pharmacol Ther. 10 (3): 292–306. doi:10.1002/cpt1969103292. PMID 4894830.
  7. ^ Charlier R (1971). Antianginal drugs: pathophysiological, haemodynamic, methodological, pharmacological, biochemical and clinical basis for their use in human therapeutics. Springer-Verlag. ISBN 978-3-540-05365-1.


pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy